- Home
- GNFT vs MRCC Comparison
GNFT vs MRCC Comparison
Compare GNFT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- MRCC
- Stock Information
- Founded
- GNFT 1999
- MRCC 2011
- Country
- GNFT France
- MRCC United States
- Employees
- GNFT N/A
- MRCC N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- MRCC Investment Managers
- Sector
- GNFT Health Care
- MRCC Finance
- Exchange
- GNFT Nasdaq
- MRCC Nasdaq
- Market Cap
- GNFT 179.7M
- MRCC 174.8M
- IPO Year
- GNFT 2019
- MRCC 2012
- Fundamental
- Price
- GNFT $3.91
- MRCC $8.54
- Analyst Decision
- GNFT Strong Buy
- MRCC Strong Buy
- Analyst Count
- GNFT 1
- MRCC 1
- Target Price
- GNFT $13.00
- MRCC $9.00
- AVG Volume (30 Days)
- GNFT 9.9K
- MRCC 48.5K
- Earning Date
- GNFT 09-19-2024
- MRCC 03-10-2025
- Dividend Yield
- GNFT N/A
- MRCC 11.64%
- EPS Growth
- GNFT N/A
- MRCC 298.01
- EPS
- GNFT 0.47
- MRCC 0.60
- Revenue
- GNFT $86,225,222.00
- MRCC $62,007,000.00
- Revenue This Year
- GNFT $145.20
- MRCC N/A
- Revenue Next Year
- GNFT N/A
- MRCC N/A
- P/E Ratio
- GNFT $7.89
- MRCC $14.20
- Revenue Growth
- GNFT 175.45
- MRCC N/A
- 52 Week Low
- GNFT $3.35
- MRCC $6.97
- 52 Week High
- GNFT $6.42
- MRCC $8.80
- Technical
- Relative Strength Index (RSI)
- GNFT 49.41
- MRCC 56.35
- Support Level
- GNFT $3.68
- MRCC $8.33
- Resistance Level
- GNFT $4.03
- MRCC $8.61
- Average True Range (ATR)
- GNFT 0.15
- MRCC 0.19
- MACD
- GNFT 0.05
- MRCC 0.01
- Stochastic Oscillator
- GNFT 57.35
- MRCC 67.44
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.